The global Alfacalcidol Market is experiencing steady expansion and is projected to grow from US$ 5.34 Billion in 2025 to US$ 8.16 Billion by 2034, registering a CAGR of 4.84% during 2026–2034.  Alfacalcidol, a vitamin D analog, is widely used in the management of osteoporosis, renal osteodystrophy, hypocalcemia, and other disorders associated with calcium and phosphate metabolism....